Skip to main content
Premium Trial:

Request an Annual Quote

Craig Mello, Christoph Westphal

Premium
Johnson & Johnson said this week that University of Massachusetts Medical School researcher and RNAi pioneer Craig Mello has been named the inaugural recipient of the Dr. Paul Janssen Award for Biomedical Research.
 
The award includes a $100,000 prize and will be given every two years.
 

 
Christoph Westphal, a founder of Alnylam Pharmaceuticals, has joined venture capital firm IDG Ventures as a senior advisor and chairman of the firm’s life sciences advisory board.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.